Lumecca IPL Lumecca IPL works using a device that emits specific wavelengths of light to target the red and brown pigments of the dermis
Filingeri noted that this research study was designed to further examine changes in weight, body fat mass, and muscle mass in patients taking incretin medications. We found that, under close supervision and regular follow-up from an obesity medicine specialist, patients were able to lose fat mass with only a minimal decline in muscle mass. Alexandra Filingeri, DCN, RCN Filingeri pointed out that the results of this study cannot be generalized to patients receiving medication via telemedicine without routine body composition analysis, nor can they be generalized to in-person visits without utilizing body composition analysis
Participants were randomly assigned to receive up to 15 mg once weekly of tirzepatide or 1.5 mg once weekly of dulaglutide for nearly four years on average
Butt, J., Jeffery, S
Regular review of body weight, nutritional status, and physical function is essential to ensure that treatment remains beneficial and does not compromise overall health
This involves precise measurement and comparison against established standards
